Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
60% premium buyout, still holding, as payback for only one on this site who saw value??
RBCN great posed question, but I believe it was not foreseeable the size of this premium!
"the unintended events" are being reduced each day by
computational and experimental methods that are bringing researchers closer to their goal of revealing exactly where in a cell or tissue each gene is expressed.
Like the notion selling diminished with flurries of upward jabs.
"the unintended events" are being reduced each day by
computational and experimental methods that are bringing researchers closer to their goal of revealing exactly where in a cell or tissue each gene is expressed.
What is easier to master. To continue on a strict diet all ones life to forestall the likely gloomy miseries, or to restrict carbon use all their life
to heal the planet?
DTIL: this guy explains DTIL well:
https://stocktwits.com/schultzeee
And to add DTIL, is best in Cart-T platform which each day
benefits cause spatial data revolution sharpening gene target
areas, previous cause of reduced success was proper target accuracy, at same time conveyer belt of partners elbowing to claim partnerships in a new disease target with probable funding,- 6,996 to go, and dozens of juicy share spiking PR's to follow!
DTIL:
I owe you one and this may be a 20 bagger with no risk at this exact point in time:
https://stocktwits.com/schultzeee
Value signaling is more important than economic productivity!
I advise all yougins to open up value signal insurgency airwave farms so they will never be besmeared.
DTIL: this guy has almost" stolen my thoughts:
https://stocktwits.com/schultzeee
May have to do all those cancer drug trials again?
".... could treatment regimens consisting of on-treatment and off-treatment periods allow for better control of cancer cell growth and, in the long term, prolong the lives of patients?"
https://medicalxpress.com/news/2022-07-importance-ecological-cellular-interactions-therapy.html
Uh oh, adaptive therapy still in it's infancy , could eventually be more effective than Cart-T?
https://medicalxpress.com/news/2022-07-device-t-cell-immunotherapies-cancer.html
MINM .42 still carrying my hate child, band playing doomsday tunes.
MICS: 8.01 torrid movement going nowhere giving me more time for the big think!
AGRX .65 start missed the last zoom as rare miss buy of a stock which went down.on miss spelling error.
OT your TMNA went from .48 to 1 while we are "waiting", you give great off message gems!
DTIL new 13G registered today with links to groups which went sort of "wild" in my view last few weeks.
:
https://www.conferencecalltranscripts.com/summary/?id=11042562
DTIL new 13G registered with links to groups which went sort of "wild" in my view last few weeks.
:
https://www.conferencecalltranscripts.com/summary/?id=11042562
OK: great! keep up the gem flow!
TMNA painted nice for the mm's earlier on scared retail slugs.
Pure .25 with no split?
I sort of like this atmosphere as many stocks with promise are being dumped before their usefulness as a bouncing debatable entity has been fully exploited.
DTIL 1.53.
Truth be told, I know nothing about the prospects of this stock to yield a net profit.
Insider selling and their funding principle to attract partners, capturing Lilly and Novartis and others already, with more insider buying from their top execs. tilts to me, a higher probable promise than suppositions I could surmise absent those facts.
The video (I linked) however suggests to me, that DTIL is the most promising scalable medical stock I can think of, even if true its ultimate success will lead to complete unfortunate failure.
The idea that this gene editing platform can conceivably be used to be effective for at least 7K diseases is crucial to proclaim its surpassing promise. The rapid new developments in new computational and experimental methods can avail foreseeing continuous increased effectiveness of this platform, even after periods of enduring inconclusive failure.
Bottom line: I can not recommend as a wise investment the stock DTIL,
But when I match DTIL against all possible investments in charitable enterprises, with the expectations of deriving no profit except tax benefits , I think DTIL is also eligible to receive a "philanthropic" donation, with no prospects of a return, except, to just be able to say, when asked to donate money for some disease, the words "I already gave".
Anyway,if anyone can name a stock with more promising scalable prospects than DTIL, it would to the highest degree, tease my curiosity.
Unfollow Board
Keyboard Sh
Re; Shingle shot ,need 2nd one soon, got first with Covid booster, felt nothing except the usual arm muscle reminder for one day..they say getting Shingles has the worst symptoms for such a benign disease you can imagine!.
PBLA went below .66 since.
DTIL 1.53.
Truth be told, I know nothing about the prospects of this stock to yield a net profit.
Insider selling and their funding principle to attract partners, capturing Lilly and Novartis and others already ,with more insider buying from their top execs. tilts to me, a higher probable promise than suppositions I could surmise absent those facts.
The video (I linked) however suggests to me, that DTIL is the most promising scalable medical stock I can think of, even if true its ultimate success will lead to complete unfortunate failure.
The idea that this gene editing platform can conceivably be used to be effective for at least 7K diseases is crucial to proclaim its surpassing promise. The rapid new developments in new computational and experimental methods can avail foreseeing continuous increased effectiveness of this platform, even after periods of enduring inconclusive failure.
Bottom line: I can not recommend as a wise investment the stock DTIL,
But when I match DTIL against all possible investments in charitable enterprises, with the expectations of deriving no profit except tax benefits , I think DTIL is also eligible to receive a "philanthropic" donation, with no prospects of a return, except, to just be able to say, when asked to donate money for some disease, the words "I already gave".
Anyway,if anyone can name a stock with more promising scalable prospects than DTIL, it would to the highest degree, tease my curiosity.
TSRI 6.88 May 18th wow.
AGRX .71- low of year was 1.09, fickle as a pickle, after .90 offering.
As major shareholder, can " he" mastermind a new underwriting once MICS shares move higher and incorporate the profit and earmark it to his "roll up" plans investing in another unrelated entity?
Bitcoin last flush and rally end of 2018 20K to 3300K then 67K in 2022.
So bitcoin 10K bottom if perfect comparison?
MICS making up what it lost after hours, too bad I only had one body to sell blood @ 2's!
TRVI 2.73.
Trevi Therapeutics Reports Positive Results from the Ph2b/3 PRISM Trial of Haduvioâ„¢ in the Treatment of Prurigo Nodularis
TRVI 2.72 up over 25% this morn.
TRVI up .70 to 2.72+!
Cart-T gene editing should improve as this field expands ability to spot where genes are in the targeted tissues:
"Computational and experimental methods are bringing researchers closer to their goal of revealing exactly where in a cell or tissue each gene is expressed."
https://www.nature.com/articles/d41586-022-01743-7?utm_source=Nature+Briefing&utm_campaign=b4de217ba9-briefing-dy-20220628&utm_medium=email&utm_term=0_c9dfd39373-b4de217ba9-44970129
TMNA see it was a tape paint seconds before the close.
TMNA closed .9899?